Apodex launches TRACES, a benchmark paradigm for how far AI can push the unknown
HeyAmit_ · x · 2026-08-25
Apodex, founded by Tianqiao Chen, launched TRACES, a new paradigm it calls "Discoverative AI." Instead of measuring how well AI answers known questions, TRACES measures how far AI can push the frontier of the unknown.
The site showcases four evaluation tracks:
- AAV Capsid: 4 tasks, 18 episodes, 11 solvers evaluated
- Drug Repurposing: Public-100 with three-seed mean ± sample SD
- Clinical Trials: gate × rigor across three ambiguity episodes
- LLM Engineering: all eleven boards, cell for cell
Related event: Apodex Unveils TRACES Benchmark to Measure AI's Ability to Discover(3 posts)→
More from AGI Musings
- Inference engine team says they're in a real RSI loop: faster engine helps build faster engine — cephaloform · 2026-10-16
- FDA pays small company to build a grading system for AI-written radiology reports — YvesMulkers · 2026-10-16
- 'If we developed AI in the 1800s, people would demand ASI to cure diabetes' — zetalyrae · 2026-10-16
- AI trained on the fraction of human intelligence that fit the page — r0ck3t23 · 2026-10-16
- Alignment researcher Turn_Trout blasts AI assistants scraping private Signal chats without consent — Turn_Trout · 2026-10-16
- Stage-4 cancer patient builds his own personalized mRNA vaccine with AI — TheMoonMidas · 2026-10-16